Psychopharmacology and Psychiatry Updates
En podcast av Psychopharmacology Institute
265 Avsnitt
-  SSRIs and Anticoagulants: Navigating Bleeding RiskPublicerades: 2025-03-12
-  Lamotrigine and the Heart: What You Need to KnowPublicerades: 2025-03-07
-  After the Last Dose: Understanding Antipsychotic DiscontinuationPublicerades: 2025-03-02
-  Understanding Lamotrigine's Cardiac EffectsPublicerades: 2025-02-25
-  Rethinking Falls: Are Sleep Medications Really to Blame?Publicerades: 2025-02-20
-  Navigating Lamotrigine's Side EffectsPublicerades: 2025-02-15
-  Iloperidone in Bipolar Disorder: A New Treatment Option?Publicerades: 2025-02-10
-  Lamotrigine: Pearls for PrescribingPublicerades: 2025-02-05
-  Beyond Benzos: New Frontiers in Agitation ManagementPublicerades: 2025-01-31
-  KarXT: A New Dawn in Antipsychotic TreatmentPublicerades: 2025-01-26
-  Rethinking Agitation Management: From Force to PartnershipPublicerades: 2025-01-21
-  COVID Brain Fog: Repurposing FamotidinePublicerades: 2025-01-16
-  Beyond Restraints: De-Escalation in Behavioral EmergenciesPublicerades: 2025-01-11
-  Rethinking Antipsychotic Dosing: Lessons from the RADAR TrialPublicerades: 2025-01-06
-  Unraveling Agitation: Mania vs. Substance UsePublicerades: 2025-01-01
-  Pushing the Boundaries: Exploring High-Dose AntipsychoticsPublicerades: 2024-12-27
-  The Psychodynamic PrescriberPublicerades: 2024-12-22
-  From Inpatient to Outpatient: Initiating Benzodiazepine TaperingPublicerades: 2024-12-17
-  The Power of Alliance in PsychopharmacologyPublicerades: 2024-12-12
-  Antipsychotics in Youth: Balancing Metabolic RiskPublicerades: 2024-12-07
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
